Ken is a co-founder and managing partner of Spring Mill Venture Partners.

Prior to Spring Mill, Ken was CEO of Cutanogen Corporation, a medical device company developing tissue-engineered skin substitute for the treatment of burns and chronic wounds, and reconstructive surgery. Before that, Ken spent eight years at Senmed Medical Ventures, a corporate venture capital firm focusing on early stage life science business opportunities. Prior to Senmed, Ken worked at Bristol Myers Squibb, and had his own private medical practice for 10 years.

Ken received his M.D. from the University of Toronto and his M.B.A. from the University of North Carolina, Kenan Flagler School of Business.